8-K: Wellgistics Health Partners with NFL Alumni Health for AI Health

Wellgistics Health announced a partnership with NFL Alumni Health to deploy its AI and blockchain technology to improve health outcomes for former NFL players and rural communities.

Summary

• Wellgistics Health, Inc. has entered into an agreement with NFL Alumni Health to establish healthcare and wellness programs.
• The partnership aims to expand access to healthcare, improve cost transparency, and drive patient outcomes, initially for former NFL players and then for broader rural communities.
• Wellgistics will leverage its proprietary EinsteinRx AI pharmacy hub and PharmacyChain smart contracts platform.
• Key health priorities include mental health, weight loss, sleep apnea, cardiometabolic disease, pain management, and Long COVID.
• NFL Alumni Health Ambassadors will support Wellgistics' healthcare access and ease-of-use message through Wellgistics' network of 6,500 independent pharmacies.
• Gary Herman was elected to the board of directors, effective February 4, 2026, and appointed Chairman of the Audit Committee.
• Mr. Herman will serve as an independent director as defined by NASDAQ and SEC rules.
• Non-employee directors receive an annual cash retainer of $120,000 (payable in cash or shares) and an annual equity award of 60,000 shares of Common Stock.
• Upon appointment, non-employee directors also receive 200,000 restricted shares of Common Stock, vesting equally over three years.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, indicating strong strategic growth potential through a significant partnership and the deployment of advanced technology in a critical market segment.

Positives

• Strategic partnership with NFL Alumni Health provides a significant client and platform for optimizing Wellgistics' technology.
• Deployment of EinsteinRx AI and PharmacyChain smart contracts demonstrates technological innovation and potential for market differentiation.
• Expansion into rural communities addresses a critical healthcare need and broadens Wellgistics' market reach beyond former NFL players.
• Focus on key health priorities like mental health and Long COVID aligns with current public health demands.
• Leveraging NFL Alumni Health Ambassadors offers a trusted community voice for promoting healthcare access.
• The election of Gary Herman as an independent director and Audit Committee Chairman strengthens corporate governance and oversight.

Risks

• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• Risks include those related to the parties' plans to negotiate definitive agreements, potential implementation, adoption, performance, revenue sharing, and other anticipated benefits of the contemplated collaboration.
• Other unanticipated factors could arise that cause actual future results to differ materially from those discussed.
• Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management's view only as of the date of the Form 8-K.

Future Outlook

The company intends to optimize its EinsteinRx and PharmacyChain platforms for organizations, starting with NFL Alumni Health as a 'white glove client.' The programs developed will initially focus on former NFL players and then be deployed more broadly in rural communities. The company expects to expand its capabilities throughout the country, with NFL Alumni Health Ambassadors helping to spread the message and encourage engagement with local pharmacies to improve health outcomes.

Management Comments

• Billy Davis, Co-Director of NFL Alumni Health: "By leveraging AI to ensure that physicians make the best prescribing decisions, medications are efficiently delivered to patients, proper support is made available to improve outcomes and smart contracts provide the oversight so that no detail is missing to ensure timely coordination of benefits and payments, Wellgistics integrated solution represents the future of healthcare. We intend to provide our alumni with best in breed healthcare, and Wellgistics is helping to make that easier."
• Prashant Patel, President & Interim-CEO of Wellgistics Health: "We are excited to partner with NFL Alumni Health as our first white glove client around whom we intend to optimize EinsteinRx and PharmacyChain to deliver the best healthcare experience for organizations. We have been making good progress with the integration of our point-of-sale EinsteinRx tool into Wellgistics Pharmacy Network pharmacies, and this now allows us to actually start developing new business for organizations because we can appropriately route prescriptions to locations that offer our full suite of services."

Industry Context

StockSavvy.ai notes that this partnership aligns with broader industry trends emphasizing the integration of artificial intelligence and blockchain technology to enhance healthcare delivery and efficiency. The focus on improving health outcomes in rural communities and for specific populations like former NFL players addresses critical gaps in healthcare access and personalized care. This move positions Wellgistics Health at the forefront of digital health innovation, leveraging its network of independent pharmacies to provide comprehensive, tech-enabled solutions.

Comparison to Industry Standards

• StockSavvy.ai notes that while the filing does not provide specific comparable companies or projects, the initiative aligns with broader industry trends focusing on leveraging AI and blockchain for healthcare optimization, particularly in underserved communities.
• The partnership with a recognized entity like NFL Alumni Health could serve as a significant case study for similar community health initiatives, potentially setting a benchmark for how technology companies can collaborate with non-profits to address public health challenges.
• The use of AI for prescription optimization (EinsteinRx) and blockchain for supply chain and benefits coordination (PharmacyChain) reflects a growing trend among health tech innovators seeking to improve transparency, reduce costs, and enhance patient adherence, similar to efforts seen in companies like IBM Watson Health (though with different specific applications) or various blockchain-in-healthcare startups aiming to secure patient data and streamline operations.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for increased revenue, market share, and long-term growth through strategic partnerships and technology deployment.
• Former NFL Players: Improved access to healthcare and wellness services, better cost transparency, and optimized health outcomes.
• Rural Communities: Expanded access to healthcare services, leveraging Wellgistics' pharmacy network and technology.
• Independent Pharmacies (Wellgistics Pharmacy Network): Potential for new business opportunities and enhanced service offerings through the EinsteinRx and PharmacyChain platforms.
• Management: Validation of strategic direction and technology platforms, with new opportunities for business development.

Next Steps

• Optimize EinsteinRx and PharmacyChain platforms for NFL Alumni Health as a 'white glove client'.
• Deploy healthcare and wellness programs more broadly in rural communities after initial optimization for former NFL players.
• NFL Alumni Health Ambassadors to help spread the message to rural communities to encourage engagement with local pharmacies.
• Continue progress with the integration of the point-of-sale EinsteinRx tool into Wellgistics Pharmacy Network pharmacies.

Key Dates

Recommendation

The strategic partnership with NFL Alumni Health represents a significant positive catalyst for Wellgistics Health. This collaboration provides a high-profile client for optimizing its proprietary AI and blockchain platforms, EinsteinRx and PharmacyChain, and offers a clear pathway for broader market penetration into underserved rural communities. The appointment of an independent director to chair the Audit Committee also strengthens corporate governance. These developments indicate strong future growth potential and improved operational efficiency, making the stock an attractive 'buy' for long-term investors.

Keywords

healthcare technology, AI, blockchain, pharmacy, NFL Alumni Health, rural health, corporate governance, independent director, health outcomes, smart contracts